Results 21 to 30 of about 5,020 (198)

Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva

open access: yesNature Communications, 2018
Fibrodysplasia ossificans progressiva is a severe disorder characterized by heterotopic ossification, and is caused by mutations in ACVR1. Here, the authors show that expression of mutant ACVR1 in fibro/adipogenic progenitors recapitulates disease ...
John B. Lees-Shepard   +13 more
doaj   +2 more sources

Update On Fragment Screening Of Acvr1 Co_Crystallised With Ldn_193189

open access: yes, 2018
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no.
Adamson, Roslin   +3 more
openaire   +3 more sources

Purification Of Acvr1 For Co_Crystallisation With Ldn_193189 And Other Compounds

open access: yes, 2018
Purification protocol for ACVR1 and crystallisation with different compounds.
Adamson, Roslin   +3 more
openaire   +3 more sources

Therapeutic targeting of PRMT5 and mutant ACVR1 in paediatric glioma [PDF]

open access: yes, 2021
Diffuse Intrinsic Pontine Glioma (DIPG) is a universally fatal paediatric brainstem tumour with a median overall survival of 9-11 months. The unique genetic, anatomical and developmental identity of the tumour means that there are currently no effective chemotherapies or targeted therapies.
openaire   +2 more sources

Purification of ACVR1 for fine screening with M4K compounds_Nov_2018

open access: yes, 2018
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no.
Adamson, Roslin   +3 more
openaire   +3 more sources

Generalized Epileptic Seizures in Fibrodysplasia Ossificans Progressiva Harboring a Recurrent Heterozygous Variant of the ACVR1 Gene (R206H)

open access: yesCase Reports in Genetics
Conclusion: This case expands our understanding of the phenotypic diversity of FOP and the functional versatility of ACVR1-mediated bone morphogenetic protein (BMP) signaling.
Kenichi Mishima   +6 more
doaj   +2 more sources

Neofunction of ACVR1 in fibrodysplasia ossificans progressiva [PDF]

open access: yesProceedings of the National Academy of Sciences, 2015
Significance By utilizing patient-specific induced pluripotent stem cells (iPSCs) of fibrodysplasia ossificans progressiva (FOP) and gene-corrected (rescued) FOP-iPSCs, we discovered a novel mechanism in ectopic bone formation: The disease-causing mutation endows ACVR1 with the ability to transmit the signal of an unexpected ligand ...
Kyosuke, Hino   +10 more
openaire   +2 more sources

Wt1 Is Required for the Regression of Müllerian Ducts in Male Mice by Inducing Wif1 and Osx Expression. [PDF]

open access: yesCell Prolif
Wt1 expressed in the MD mesenchyme promotes MD regression by inducing Wif1 and Osx transcription. In male mice, mesenchyme‐specific inactivation of Wt1 results in MD retention. ABSTRACT In mammals, Müllerian ducts (MDs) are the precursors of the female reproductive tract which regress in males during embryonic development.
Chen M   +12 more
europepmc   +2 more sources

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma. [PDF]

open access: yes, 2021
Somatic mutations in ACVR1 are found in a quarter of children with diffuse intrinsic pontine glioma (DIPG), but there are no ACVR1 inhibitors licensed for the disease.
Merve, A   +89 more
core   +1 more source

Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish

open access: yeseLife, 2020
Fibrodysplasia ossificans progressiva (FOP) is a rare human genetic disorder characterized by altered skeletal development and extraskeletal ossification.
Robyn S Allen   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy